• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺免疫预后指数可预测骨肉瘤患者的转移情况。

Lung Immune Prognostic Index Could Predict Metastasis in Patients With Osteosarcoma.

作者信息

He Xuanhong, Wang Yitian, Ye Qiang, Wang Yang, Min Li, Luo Yi, Zhou Yong, Tu Chongqi

机构信息

Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Surg. 2022 Jul 8;9:923427. doi: 10.3389/fsurg.2022.923427. eCollection 2022.

DOI:10.3389/fsurg.2022.923427
PMID:35874141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9304694/
Abstract

BACKGROUND

The lung immune prognostic index (LIPI), composed of serum lactate dehydrogenase (LDH) and the derived neutrophil to lymphocyte ratio (dNLR), is a novel prognostic factor of lung cancer. The prognostic effect of the LIPI has never been verified in osteosarcoma.

METHODS

We retrospectively reviewed the osteosarcoma patients with metachronous metastasis from January 2016 to January 2021 in West China Hospital. We collected and analyzed the clinical data and constructed the LIPI for osteosarcoma. The correlation between the LIPI and metastasis was analyzed according to the Kaplan-Meier method and Cox regression analysis with hazard ratios (HRs) and 95% confidence intervals (CIs). Univariate analysis and multivariate analysis were conducted to clarify the independent risk factors of metastasis. The nomogram model was established by R software, version 4.1.0.

RESULTS

The area under the curve (AUC) and best cutoff value were 0.535 and 91, 0.519, and 5.02, 0.594 and 2.77, 0.569 and 227.14, 0.59 and 158, and 0.607 and 2.05 for ALP, LMR, NLR, PLR, LDH, and dNLR, respectively. The LIPI was composed of LDH and dNLR and showed a larger AUC than other hematological factors in the time-dependent operator curve (t-ROC). In total, 184 patients, 42 (22.8%), 96 (52.2%), and 46 (25.0%) patients had LIPIs of good, moderate, and poor, respectively ( < 0.0001). Univariate analysis revealed that pathological fracture, the initial CT report of suspicious nodule, and the NLR, PLR, ALP, and the LIPI were significantly associated with metastasis, and multivariate analysis showed that the initial CT report of suspicious nodule and the PLR, ALP, and LIPI were dependent risk factors for metastasis. Metastatic predictive factors were selected and incorporated into the nomogram construction, including the LIPI, ALP, PLR, initial CT report, and pathological fracture. The C-index of our model was 0.71. According to the calibration plot, this predictive nomogram could accurately predict 3- and 5-year metachronous metastasis. Based on the result of decision curve and clinical impact curve, this predictive nomogram could also help patients obtain significant net benefits.

CONCLUSION

We first demonstrated the metastatic predictive effect of the LIPI on osteosarcoma. This LIPI-based model is useful for clinicians to predict metastasis in osteosarcoma patients and could help conduct timely intervention and facilitate personalized management of osteosarcoma patients.

摘要

背景

肺免疫预后指数(LIPI)由血清乳酸脱氢酶(LDH)和衍生的中性粒细胞与淋巴细胞比值(dNLR)组成,是肺癌的一种新型预后因素。LIPI在骨肉瘤中的预后作用尚未得到验证。

方法

我们回顾性分析了2016年1月至2021年1月在华西医院发生异时性转移的骨肉瘤患者。我们收集并分析了临床数据,并构建了骨肉瘤的LIPI。根据Kaplan-Meier法和Cox回归分析,分析LIPI与转移之间的相关性,并计算风险比(HRs)和95%置信区间(CIs)。进行单因素分析和多因素分析以阐明转移的独立危险因素。使用R软件4.1.0版建立列线图模型。

结果

碱性磷酸酶(ALP)、淋巴细胞与单核细胞比值(LMR)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、LDH和dNLR的曲线下面积(AUC)及最佳截断值分别为0.535和91、0.519和5.02、0.594和2.77、0.569和227.14、0.59和158、0.607和2.05。LIPI由LDH和dNLR组成,在时间依赖性操作曲线(t-ROC)中显示出比其他血液学因素更大的AUC。总共184例患者中,LIPI良好、中等和较差的患者分别有42例(22.8%)、96例(52.2%)和46例(25.0%)(<0.0001)。单因素分析显示,病理性骨折、可疑结节的初始CT报告以及NLR、PLR、ALP和LIPI与转移显著相关,多因素分析表明,可疑结节的初始CT报告以及PLR、ALP和LIPI是转移的独立危险因素。选择转移预测因素并纳入列线图构建,包括LIPI、ALP、PLR、初始CT报告和病理性骨折。我们模型的C指数为0.71。根据校准图,该预测列线图可以准确预测3年和5年异时性转移。根据决策曲线和临床影响曲线的结果,该预测列线图还可以帮助患者获得显著的净效益。

结论

我们首次证明了LIPI对骨肉瘤的转移预测作用。这种基于LIPI的模型有助于临床医生预测骨肉瘤患者的转移情况,并有助于及时进行干预,促进骨肉瘤患者的个性化管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c1/9304694/7359a7bdbb9a/fsurg-09-923427-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c1/9304694/7ab9b524e708/fsurg-09-923427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c1/9304694/aaea7435e90f/fsurg-09-923427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c1/9304694/6f629092a0ff/fsurg-09-923427-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c1/9304694/5366ab5ba0ab/fsurg-09-923427-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c1/9304694/7359a7bdbb9a/fsurg-09-923427-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c1/9304694/7ab9b524e708/fsurg-09-923427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c1/9304694/aaea7435e90f/fsurg-09-923427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c1/9304694/6f629092a0ff/fsurg-09-923427-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c1/9304694/5366ab5ba0ab/fsurg-09-923427-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c1/9304694/7359a7bdbb9a/fsurg-09-923427-g005.jpg

相似文献

1
Lung Immune Prognostic Index Could Predict Metastasis in Patients With Osteosarcoma.肺免疫预后指数可预测骨肉瘤患者的转移情况。
Front Surg. 2022 Jul 8;9:923427. doi: 10.3389/fsurg.2022.923427. eCollection 2022.
2
Prognostic significance of modified lung immune prognostic index in osteosarcoma patients.改良肺免疫预后指数在骨肉瘤患者中的预后意义
Front Genet. 2022 Oct 11;13:972352. doi: 10.3389/fgene.2022.972352. eCollection 2022.
3
The application of lung immune prognostic index in predicting the prognosis of 302 STS patients.肺免疫预后指数在预测302例软组织肉瘤患者预后中的应用。
Front Oncol. 2024 Sep 9;14:1460600. doi: 10.3389/fonc.2024.1460600. eCollection 2024.
4
Analysis of the immune-inflammatory indices for patients with metastatic hormone-sensitive and castration-resistant prostate cancer.转移性激素敏感和去势抵抗性前列腺癌患者免疫炎症指标分析。
BMC Cancer. 2024 Jul 9;24(1):817. doi: 10.1186/s12885-024-12593-z.
5
Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma.肺免疫预后指数在食管鳞状细胞癌切除患者中的预后意义
Cancer Manag Res. 2021 Mar 26;13:2811-2819. doi: 10.2147/CMAR.S298412. eCollection 2021.
6
[Effect of dNLR and LIPI scores on the prognosis of elderly patients with non-surgical treatment of non-small cell lung cancer].[中性粒细胞与淋巴细胞比值(dNLR)和肺免疫预后指数(LIPI)评分对老年非小细胞肺癌非手术治疗患者预后的影响]
Zhonghua Zhong Liu Za Zhi. 2022 Sep 23;44(9):975-980. doi: 10.3760/cma.j.cn112152-20200423-00371.
7
Osteosarcoma immune prognostic index can indicate the nature of indeterminate pulmonary nodules and predict the metachronous metastasis in osteosarcoma patients.骨肉瘤免疫预后指数可提示骨肉瘤患者中不确定肺结节的性质,并预测异时转移。
Front Oncol. 2022 Jul 22;12:952228. doi: 10.3389/fonc.2022.952228. eCollection 2022.
8
Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy.一线PD-1/PD-L1抑制剂联合化疗治疗的晚期小细胞肺癌患者治疗前肺免疫预后指数的预后价值
Front Oncol. 2021 Oct 8;11:697865. doi: 10.3389/fonc.2021.697865. eCollection 2021.
9
Clinical Significance of Serum Biomarkers in Stage IV Non-Small-Cell Lung Cancer Treated with PD-1 Inhibitors: LIPI Score, NLR, dNLR, LMR, and PAB.血清生物标志物在 PD-1 抑制剂治疗 IV 期非小细胞肺癌中的临床意义:LIPI 评分、NLR、dNLR、LMR 和 PAB。
Dis Markers. 2022 Jul 30;2022:7137357. doi: 10.1155/2022/7137357. eCollection 2022.
10
Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection.术前肺免疫预后指数可预测接受根治性切除的胰腺癌患者的生存情况。
Front Surg. 2023 Jan 6;9:1002075. doi: 10.3389/fsurg.2022.1002075. eCollection 2022.

引用本文的文献

1
Increased Pre-Operative Lung Immune Prognostic Index Score Is a Prognostic Factor in Cases of Pathological T3 Renal Cell Carcinoma.术前肺免疫预后指数评分升高是病理T3期肾细胞癌病例的一个预后因素。
Curr Oncol. 2025 Jun 7;32(6):335. doi: 10.3390/curroncol32060335.
2
Association of lung immune prognostic index with overall survival in pancreatic ductal adenocarcinoma patients treated using chemotherapy.肺免疫预后指数与接受化疗的胰腺导管腺癌患者总生存期的关联
Int J Med Sci. 2025 Mar 3;22(7):1672-1679. doi: 10.7150/ijms.102404. eCollection 2025.
3
Electrolyte prognosis scoring system can predict overall survival in patients with osteosarcoma.

本文引用的文献

1
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.衍生中性粒细胞与淋巴细胞比值可预测乳腺癌新辅助化疗后的病理完全缓解情况。
Front Oncol. 2022 Feb 11;11:827625. doi: 10.3389/fonc.2021.827625. eCollection 2021.
2
Pretreatment Neutrophil Count and Platelet-lymphocyte Ratio as Predictors of Metastasis in Patients With Osteosarcoma.治疗前中性粒细胞计数和血小板-淋巴细胞比值可预测骨肉瘤患者的转移。
Anticancer Res. 2022 Feb;42(2):1081-1089. doi: 10.21873/anticanres.15570.
3
Osteosarcoma and Metastasis.
电解质预后评分系统可以预测骨肉瘤患者的总生存期。
Front Oncol. 2024 Oct 9;14:1466912. doi: 10.3389/fonc.2024.1466912. eCollection 2024.
4
The application of lung immune prognostic index in predicting the prognosis of 302 STS patients.肺免疫预后指数在预测302例软组织肉瘤患者预后中的应用。
Front Oncol. 2024 Sep 9;14:1460600. doi: 10.3389/fonc.2024.1460600. eCollection 2024.
5
The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive.OSR9 方案:一种使用来自普通医学的九种老药抑制生长驱动的骨肉瘤治疗新增强策略。
Int J Mol Sci. 2023 Oct 23;24(20):15474. doi: 10.3390/ijms242015474.
6
Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection.术前肺免疫预后指数可预测接受根治性切除的胰腺癌患者的生存情况。
Front Surg. 2023 Jan 6;9:1002075. doi: 10.3389/fsurg.2022.1002075. eCollection 2022.
骨肉瘤与转移
Front Oncol. 2021 Dec 10;11:780264. doi: 10.3389/fonc.2021.780264. eCollection 2021.
4
A Nomogram Based on Circulating CD4 T Lymphocytes and Lactate Dehydrogenase to Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma.基于循环CD4 T淋巴细胞和乳酸脱氢酶的列线图预测鼻咽癌患者远处转移
J Inflamm Res. 2021 Dec 9;14:6707-6718. doi: 10.2147/JIR.S341897. eCollection 2021.
5
The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy.术前肺部免疫预后指数在接受根治性膀胱切除术的膀胱癌患者中的预后价值。
Int J Clin Oncol. 2022 Feb;27(2):396-402. doi: 10.1007/s10147-021-02059-8. Epub 2021 Oct 29.
6
Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study.新诊断骨肉瘤患者远处转移的危险因素、预后因素及列线图:一项基于人群的研究
Front Endocrinol (Lausanne). 2021 Jul 30;12:672024. doi: 10.3389/fendo.2021.672024. eCollection 2021.
7
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors.错配修复缺陷肿瘤中肺免疫预后指数与免疫治疗结果的关联
Cancers (Basel). 2021 Jul 27;13(15):3776. doi: 10.3390/cancers13153776.
8
Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.建立并验证一个列线图预测模型,用于预测放疗后 6 个月内鼻咽癌患者的早期转移,以指导强化治疗。
Radiother Oncol. 2021 Sep;162:202-211. doi: 10.1016/j.radonc.2021.03.035. Epub 2021 Apr 9.
9
Nomograms predicting primary lymph node metastases and prognosis for synchronous colorectal liver metastasis with simultaneous resection of colorectal cancer and liver metastases.预测同时性结直肠癌肝转移患者行结直肠癌和肝转移灶同期切除术后原发性淋巴结转移及预后的列线图。
Ann Palliat Med. 2021 Apr;10(4):4220-4231. doi: 10.21037/apm-20-2303. Epub 2021 Mar 23.
10
Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration.与骨肉瘤转移和免疫浸润相关的缺氧相关预后标志物的开发与验证
Front Cell Dev Biol. 2021 Mar 18;9:633607. doi: 10.3389/fcell.2021.633607. eCollection 2021.